AC
GOSS icon

AlphaCore Capital’s Gossamer Bio GOSS Stock Holding History

AlphaCore Capital’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.4K Buy
69,482
+16,471
+31% +$4.6K ﹤0.01% 1391
2026
Q1 		$17.4K Buy
53,011
+26,634
+101% +$41.9K ﹤0.01% 1083
2025
Q4 		$81.8K Buy
+26,377
New +$75.3K ﹤0.01% 1117

Other funds holding GOSS

D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
DIG
DeepCurrents Investment Group New York $3.3B AUM 12.57% 1-Year Est. Return
CCM
Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $44.3M AUM 34.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $174M AUM

AlphaCore Capital's GOSS Position: Q2 2026 in Review

AlphaCore Capital increased its Gossamer Bio (GOSS) stake by 31% in Q2 2026, buying an estimated $4.6K and bringing the position to 69,482 shares worth $11.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1391.

AlphaCore Capital first reported a position in GOSS in Q4 2025 and has held it in 3 quarters since. The position peaked at $81.8K in Q4 2025. 170 funds tracked by Wall St. Rank hold GOSS as of Q2 2026.

  • AlphaCore Capital held 69,482 shares of Gossamer Bio worth $11.4K as of Q2 2026.
  • AlphaCore Capital bought 16,471 Gossamer Bio shares in Q2 2026, an estimated $4.6K.
  • Gossamer Bio made up ﹤0.01% of AlphaCore Capital's portfolio in Q2 2026, its #1391 holding.
  • AlphaCore Capital first reported a position in Gossamer Bio in Q4 2025 and has held it in 3 quarters since.
  • AlphaCore Capital's Gossamer Bio position peaked at $81.8K in Q4 2025.
  • 170 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2026.

Based on AlphaCore Capital's 13F filing for Q2 2026, filed 6 Aug 2026.